Overview
An AI-native clinical research organization combining trial agents with human review.
What Nxtcure Labs does
Nxtcure Labs is developing a full-stack clinical research offering around Galen, its clinical-trial agent system. Specialized agents cover activities such as feasibility, protocol preparation, recruitment, monitoring, data management, safety and study documentation.
The workflow runs trial operations in lifecycle order and brings decisions into a shared review queue. Actions with clinical, safety, regulatory or financial consequences require qualified human approval rather than being executed as unrestricted autonomous decisions.
Its public product demonstrations use study datasets to show the operating model. The offering is an early-stage AI-native CRO approach, bringing software execution and professional review together across trial operations.
Company details
- Headquarters
- San Francisco (YC-listed location)
- Founded
- 2026
Founders & leadership
Investors & backers
Y Combinator lists Nxtcure Labs in its company directory. No funding amount is inferred from participation.
Y Combinator
